Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment.Full disclaimer·
The review discusses traditional hair loss treatments like minoxidil and finasteride, and newer options like Low-Level Laser Therapy, microneedling, and platelet-rich plasma for androgeneticalopecia. It highlights the need for more high-quality trials to assess these treatments' effectiveness and standardized protocols for emerging therapies.
The conversation discusses treatments for AndrogeneticAlopecia, including Minoxidil, finasteride, RU58841, and topical caffeine. It emphasizes that there are multiple treatment options available in 2025.
The user experienced hair loss starting in 2020-21, with significant thinning by 2024. They used finasteride, dutasteride, and oral minoxidil, seeing regrowth initially but faced setbacks due to medication interruptions and other factors, leading to thinning again.
Current treatments for hair loss include finasteride, minoxidil, and derma rolling. New treatments like Breezula, PP405, and others are not expected until at least 2027 or later.
A 55-year-old male has been managing hair loss with finasteride for 15 years and switched to dutasteride in 2022 due to thinning. He also uses minoxidil, PRP treatments, and ketoconazole shampoo, and is considering a shorter hairstyle for more volume.
A 30-year-old male with androgenicalopecia started using topical Minoxidil in 2018, Finasteride in 2020, and switched to oral Minoxidil and Dutasteride after Finasteride stopped working. He underwent hair transplants in 2022 and 2025, showing significant improvement in recent photos.